Menu Search
Equities

Comprehensive Healthcare Systems Inc

CHS:CVE

Comprehensive Healthcare Systems Inc

Actions
  • Price (CAD)0.005
  • Today's Change0.00 / 0.00%
  • Shares traded51.00k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Jul 05 2024 14:30 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Comprehensive Healthcare Systems, Inc. is a vertically integrated software-as-a-service (SaaS) company. The Company is focused on digitizing healthcare with Healthcare Benefits Administration solutions, providing transaction capable systems. It offers benefits admin software, third party administrator, data and pricing transparency, medical management, pharmacy benefit management and financial recovery. Its Novus 360 Healthcare Welfare and Benefits Administration (HWBA) SaaS platform is used by clients for all aspects of healthcare benefits administration (including self-funded employers, providers, and labor unions), providing healthcare administrative software and technology-enabled services. Its Novus 360 Third Party Administrator service provides everything their organization needs to benefit administration management. Its subsidiaries include Comprehensive Healthcare Systems Inc., Health Plan Systems, Inc., New York Medical Management, Inc. and Health Plan Systems Services Corp.

  • Revenue in USD (TTM)3.68m
  • Net income in USD-1.70m
  • Incorporated2018
  • Employees--
  • Location
    Comprehensive Healthcare Systems Inc2025 Lincoln HighwayState Route 27 - Suite 340EDISON 08817United StatesUSA
  • Phone+1 (403) 613-7310
  • Fax+1 (403) 613-7310
  • Websitehttps://www.comphealthcare.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.